Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Endocrine Reviews|April 8, 2022
Clinical Biology of the Pituitary AdenomaShlomo Melmed, Ursula B Kaiser, M Beatriz Lopes, et al.
European Journal of Endocrinology|June 26, 2020
Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinomaLucie Allard, Frédérique Albarel, Jérôme Bertherat, et al.
European Journal of Endocrinology|March 7, 2024
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trialBlandine Gatta-Cherifi, Kamel Mohammedi, Tanguy Cariou, et al.
European Journal of Endocrinology|August 19, 2024
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort studyDario De Alcubierre, Grigorios Gkasdaris, Margaux Mordrel, et al.
European Journal of Endocrinology|September 18, 2023
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumoursJulia Simon, Luis Gustavo Perez-Rivas, Yining Zhao, et al.
European Journal of Endocrinology|January 22, 2024
Carney complex predisposes to breast cancer: prospective study of 50 womenPatricia Vaduva, Florian Violon, Anne Jouinot, et al.
European Journal of Endocrinology|December 17, 2025
PRKACA constitutional duplication: a specific cause of primary pigmented nodular adrenocortical diseasePatricia Vaduva, Florian Violon, Albain Chansavang, et al.
The Lancet. Diabetes & Endocrinology|December 26, 2021
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trialMaria Fleseriu, Alexander Dreval, Irina Bondar, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2025
PDE11A is a phenotype modulator of Primary Bilateral Macronodular Adrenal Hyperplasia: results of a 334 patients' seriesPatricia Vaduva, Lucas Bouys, Anne Jouinot, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2024
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral PaltusotineMônica R Gadelha, Alessandra Casagrande, Christian J Strasburger, et al.
Pageof 8